Predictors | Regression coefficients | SE | OR (95% CI) | P value |
Sex | ||||
Women | Reference category | |||
Men | 0.742 | 0.112 | 2.10 (1.68 to 2.62) | <0.001 |
Age (years) | ||||
<40 | Reference category | |||
40–49 | 1.227 | 0.464 | 3.41 (1.37 to 8.48) | 0.008 |
50–59 | 2.478 | 0.414 | 11.92 (5.30 to 26.81) | <0.001 |
60–69 | 3.424 | 0.399 | 30.68 (14.04 to 67.04) | <0.001 |
70–79 | 4.109 | 0.398 | 60.89 (27.93 to 132.73) | <0.001 |
80–89 | 4.725 | 0.400 | 112.68 (51.48 to 246.63) | <0.001 |
90+ | 5.299 | 0.428 | 200.12 (86.50 to 462.97) | <0.001 |
Comorbidities | ||||
Chronic kidney disease | 0.679 | 0.157 | 1.97 (1.45 to 2.68) | <0.001 |
Chronic obstructive pulmonary disease | 0.436 | 0.144 | 1.55 (1.17 to 2.05) | 0.002 |
Recent history of cancer (≤5 years) | 0.432 | 0.194 | 1.54 (1.05 to 2.25) | 0.026 |
Chronic heart failure | 0.408 | 0.166 | 1.50 (1.09 to 2.08) | 0.014 |
Acid-related disorders | 0.382 | 0.118 | 1.47 (1.16 to 1.85) | 0.001 |
Diabetes mellitus | 0.323 | 0.129 | 1.38 (1.07 to 1.78) | 0.012 |
Intercept | −6.448 | 0.386 | – | <0.001 |
Overall predictive power: AUC (95% CI): 0.893 (0.880 to 0.907); sensitivity: 85.8% and specificity: 80.3%.
Age, sex and comorbidities from table 1 were entered into the model.